Literature DB >> 22231071

Incyte comes of age with JAK inhibitor approval.

Nuala Moran.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22231071     DOI： 10.1038/nbt0112-3

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Pfizer's JAK inhibitor sails through phase 3 in rheumatoid arthritis.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2011-06-07       Impact factor: 54.908
  1 in total
  9 in total

1.  Fresh from the biotech pipeline--2011 [corrected].

Authors:  Jim Kling
Journal:  Nat Biotechnol       Date:  2012-02-08       Impact factor: 54.908

2.  Debunking the myth that whole-genome sequencing infringes thousands of gene patents.

Authors:  Christopher M Holman
Journal:  Nat Biotechnol       Date:  2012-03-07       Impact factor: 54.908

3.  Setback for JAK2 inhibitors.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2014-02       Impact factor: 54.908

4.  RNAi-based modulation of IFN-γ signaling in skin.

Authors:  Qi Tang; Jacquelyn Sousa; Dimas Echeverria; Xueli Fan; Ying-Chao Hsueh; Khashayar Afshari; Nicholas MeHugh; David A Cooper; Lorenc Vangjeli; Kathryn Monopoli; Ken Okamura; Annabelle Biscans; Adam Clauss; John E Harris; Anastasia Khvorova
Journal:  Mol Ther       Date:  2022-04-27       Impact factor: 12.910

Review 5.  Big opportunities for small molecules in immuno-oncology.

Authors:  Jerry L Adams; James Smothers; Roopa Srinivasan; Axel Hoos
Journal:  Nat Rev Drug Discov       Date:  2015-07-31       Impact factor: 84.694

6.  Nintedanib ameliorates animal model of dermatitis.

Authors:  Min-Jeong Heo; Chanmi Lee; Soo Young Choi; Yeong Min Choi; In-Sook An; Seunghee Bae; Sungkwan An; Jin Hyuk Jung
Journal:  Sci Rep       Date:  2020-03-11       Impact factor: 4.379

Review 7.  Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?

Authors:  Paul Beinhoff; Lavannya Sabharwal; Vindhya Udhane; Cristina Maranto; Peter S LaViolette; Kenneth M Jacobsohn; Susan Tsai; Kenneth A Iczkowski; Liang Wang; William A Hall; Scott M Dehm; Deepak Kilari; Marja T Nevalainen
Journal:  Cancers (Basel)       Date:  2021-10-17       Impact factor: 6.575

Review 8.  Cytokine Signaling in Tumor Progression.

Authors:  Myungmi Lee; Inmoo Rhee
Journal:  Immune Netw       Date:  2017-08-09       Impact factor: 6.303

9.  Roles of existing drug and drug targets for COVID-19 management.

Authors:  Akeberegn Gorems Ayele; Engidaw Fentahun Enyew; Zemene Demelash Kifle
Journal:  Metabol Open       Date:  2021-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.